Initial Statement of Beneficial Ownership Filing by Camac Partners, LLC

Camac Partners, LLC, along with its affiliates Camac Capital, LLC and Camac Fund, LP, and its manager Eric Shahinian, have collectively acquired beneficial ownership of 430,900 shares of Cryo-Cell International, Inc. common stock, representing approximately 5.3% of the outstanding shares. The total purchase price for these shares was approximately $1,354,672. The Reporting Persons acquired these shares believing them to be undervalued and may increase or decrease their positions in the future. They also intend to review their investment periodically and may engage in discussions with the company's management and board regarding various corporate matters, including board composition, corporate governance, asset monetization, and return of capital to shareholders. The filing details transactions made by Camac Fund, LP over the past 60 days, with purchases ranging in price from $2.964 to $3.410 per share.